Accepting new patients
Prof. Dr.
Dr Mark Nathan
Oncology
- 🇬🇧
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Dr Mark Nathan
Dr Mark Nathan is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust having joined in 2017. He specialises in treating breast cancer, working at Guys Hospital as well as Kings Hospital and Queen Mary's Hospital in Sidcup. He is involved in the running of clinical trials at Guys Hospital. Dr Nathan originates from London and graduated from the Bart's and the London Medical School in 2006. He undertook his basic training in and around North East London before returning to complete his higher Oncology training at St Bartholomew's Hospital. He spent three years obtaining his PhD as an AVON clinical research fellow at the Breakthrough Breast Cancer Research Centre where he also participated in clinics at the Royal Marsden Hospital. Diseases, Medical Tests and Treatments • The management of early and metastatic breast cancer • The management of early and metastatic breast cancer
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-434111
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-82A93985
Renewal due 2037
Verify with issuerMalpractice cover
Generali Healthcare
1,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2016–2022
MD · Medicine and Surgery
Universidad de Navarra
-
2022–2026
Residency · Oncology
Universitat de València
Career & appointments
-
2026-09–2027-08
Junior consultant
Universidad de Navarra Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
1,406 |
| Annual physical exam | 99395 |
2,336 |
| Vaccination administration | 90471 |
2,200 |
| Minor procedure (skin) | 17110 |
2,327 |
Patient reviews
See all 5213"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2027
- national college of family doctors — Member · since 2027
- European Union of Medical Specialists (UEMS) — Member · since 2027
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Research & publications
h-index: 12 · i10: 8
Selected publications
-
Long-term follow-up of Oncology across
DOI: 10.4303/euroclin.2026.0 · cited by 62
-
Validation of clinical scoring in Oncology
DOI: 10.6585/euroclin.2025.1 · cited by 44
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Dr Mark Nathan
Frequently asked
01. Do you accept new patients?
Dr Mark Nathan is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
Please use the booking flow to enter your insurance — we verify and confirm before your slot.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.